Contact
Clive S. Zent, M.D.
View Contact & SchedulingLocations
Strong Memorial Hospital
90 Crittenden Boulevard
Rochester, NY 14642
About Me
Conditions I Treat:
- Chronic lymphocytic leukemia/Small lymphocytic lymphoma (CLL)
- Hairy cell leukemia
- Prolymphocytic leukemia
- Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)
- Large granular lymphocytic leukemia
Faculty Appointments
Professor - Department of Medicine, Hematology/Oncology (SMD)
Credentials
Residency & Fellowship
Residency, Internal Medicine, University of Arkansas College of Medicine. 1996 - 1997
Fellowship, Hematology & Oncology, University of Chicago Medical Center. 1993 - 1996
Residency, Internal Medicine, Groote Schuur Hospital (South Africa). 1987 - 1991
Internship, Internal Medicine, Coronation Hospital (South Africa). 1984 - 1984
Education
MBBCH | University of Witwatersrand (South Africa). 1983
Awards
Teacher of the Year in Hematology. 2008
Kaminer Fellowship (Travel Award). 1995
Degree with Distinction. 1983
Research
Research Lab
Clinical Trials
Lead Researcher: Clive S Zent
This phase II trial studies the effects of venetoclax and rituximab in comparison to ibrutinib and rituximab in treating patients with previously untreated Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma. Ibrutinib may stop the growth of c...
Publications
Journal Articles
Grever M, Andritsos L, Anghelina M, Arons E, Banerji V, Barrientos J, Bhat SA, Blachly J, Broccoli A, Call T, Dearden C, Dietrich S, Else M, Epperla N, Fagarasanu A, Falini B, Forconi F, Gozzetti A, Hampel P, Hermel DJ, Iyengar S, Johnston JB, Juliusson G, Kreitman RJ, Lauria F, Lozanski G, Oakes CC, Parikh SA, Park J, Quest G, Rai K, Ravandi F, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Tiacci E, Troussard X, Wörmann B, Zent CS, Zenz T, Zinzani PL
Leukemia.. 2024 July 38 (7):1642-1644. Epub 06/08/2024.
Hill BT, Ma S, Zent CS, Baran AM, Wallace DS, Advani AS, Winter AM, Winter JN, Gordon LI, Karmali R, Liesveld JL, Mulford DA, Rowland C, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Barr PM
Blood advances.. 2024 January 238 (2):378-387. Epub 1900 01 01.
Brady MT, Laniewski N, Strawderman M, Chu CC, Kanagaiah P, Sangster MY, Topham DJ, Friedberg JW, Zent CS
American journal of hematology.. 2023 October 98 (10):E288-E290. Epub 07/23/2023.
Van Wagoner CM, Rivera-Escalera F, Jaimes-Delgadillo NC, Chu CC, Zent CS, Elliott MR
Immunological reviews.. 2023 October 319 (1):128-141. Epub 08/21/2023.
Ojo A, Goldenberg I, McNitt S, Schleede S, Casulo C, Zent CS, Moore J, Soniwala M, Aktas MK, Sherazi S
JACC. Advances.. 2023 October 2 (8):100602. Epub 09/12/2023.
Thapa K, Strawderman M, Reagan PM, Barr PM, Zent CS, Friedberg JW, Faugh T, Casulo C
Clinical lymphoma, myeloma & leukemia.. 2023 September 23 (9):e260-e267. Epub 05/23/2023.
Wallace DS, Zent CS, Baran AM, Reagan PM, Casulo C, Rice G, Friedberg JW, Barr PM
Blood advances.. 2023 June 137 (11):2496-2503. Epub 1900 01 01.
Moore JE, Bloom PC, Chu CC, Bruno JE, Herne CA, Baran AM, Quataert SA, Mosmann TR, Taylor RP, Wallace DS, Elliott MR, Barr PM, Zent CS
Leukemia research.. 2023 June 129 :107072. Epub 03/29/2023.
Epperla N, Zhao Q, Anghelina M, Neal J, Blachly JS, Rogers KA, Lozanski G, Oakes CC, Bhat SA, Zent CS, Banerji V, Grever M, Andritsos L
American journal of hematology.. 2023 May 98 (5):E116-E118. Epub 02/24/2023.
Archibald WJ, Baran AM, Williams AM, Salloum RM, Richard Burack W, Evans AG, Syposs CR, Zent CS
Leukemia research.. 2023 May 128 :107053. Epub 03/02/2023.
Sherazi S, Schleede S, McNitt S, Casulo C, Moore JE, Storozynsky E, Patel A, Vidula N, Aktas MK, Zent CS, Goldenberg I
Journal of the American Heart Association.. 2023 March 2112 (6):e025786. Epub 03/09/2023.
Ravandi F, Kreitman RJ, Tiacci E, Andritsos L, Banerji V, Barrientos JC, Bhat SA, Blachly JS, Broccoli A, Call T, Chihara D, Dearden C, Demeter J, Dietrich S, Else M, Epperla N, Falini B, Forconi F, Gladstone DE, Gozzetti A, Iyengar S, Johnston JB, Jorgensen J, Juliusson G, Lauria F, Lozanski G, Parikh SA, Park JH, Polliack A, Quest G, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Thompson PA, Troussard X, Zent CS, Zenz T, Zinzani PL, Wörmann B, Rai K, Grever M
Blood cancer journal.. 2022 December 1312 (12):165. Epub 12/13/2022.
Andritsos LA, Anghelina M, Neal J, Blachly JS, Mathur P, Lele O, Dearden C, Iyengar S, Cross M, Zent CS, Rogers KA, Epperla N, Lozanski G, Oakes CC, Kraut E, Ruppert AS, Zhao Q, Bhat SA, Forconi F, Banerji V, Handunnetti S, Tam CS, Seymour JF, Else M, Kreitman RJ, Saven A, Call T, Parikh SA, Ravandi F, Johnston JB, Tiacci E, Troussard X, Tallman MS, Dietrich S, Tadmor T, Gozzetti A, Zinzani PL, Robak T, Quest G, Demeter J, Rai K, Fernandez SA, Grever M
Leukemia & lymphoma.. 2022 December 63 (13):3021-3031. Epub 09/07/2022.
Anghelina M, Naughton MJ, Zhao Q, Ruppert AS, Neal J, Rogers KA, Blachly JS, Lozanski G, Bhat SA, Kraut E, Epperla N, Mathur P, Zent CS, Banerji V, Dearden C, Hutchinson T, Grever M, Andritsos LA
Leukemia research.. 2022 October 121 :106943. Epub 09/02/2022.
Anghelina M, Naughton MJ, Zhao Q, Ruppert AS, Neal J, Rogers KA, Blachly JS, Lozanski G, Bhat SA, Kraut E, Epperla N, Mathur P, Zent CS, Banerji V, Dearden C, Hutchinson T, Grever M, Andritsos LA
Leukemia research.. 2022 September 120 :106919. Epub 07/18/2022.
Pinney JJ, Blick-Nitko SK, Baran AM, Peterson DR, Whitehead HE, Izumi R, Munugalavadla V, Van DerMeid KR, Barr PM, Zent CS, Elliott MR, Chu CC
Haematologica.. 2022 June 1107 (6):1460-1465. Epub 06/01/2022.
Nkosi D, Zent CS, El Hussein S
EJHaem.. 2022 May 3 (2):553-554. Epub 04/19/2022.
Zent CS
Clinical cancer research : an official journal of the American Association for Cancer Research.. 2021 August 1527 (16):4465-4467. Epub 06/09/2021.
Grever M, Andritsos L, Banerji V, Barrientos JC, Bhat S, Blachly JS, Call T, Cross M, Dearden C, Demeter J, Dietrich S, Falini B, Forconi F, Gladstone DE, Gozzetti A, Iyengar S, Johnston JB, Juliusson G, Kraut E, Kreitman RJ, Lauria F, Lozanski G, Parikh SA, Park J, Polliack A, Ravandi F, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Tiacci E, Troussard X, Zent C, Zenz T, Zinzani PL, Wörmann B
Leukemia.. 2021 July 35 (7):1864-1872. Epub 05/04/2021.
Zent CS, Brady MT, Delage C, Strawderman M, Laniewski N, Contant PN, Kanagaiah P, Sangster MY, Barr PM, Chu CC, Topham DJ, Friedberg JW
Leukemia.. 2021 June 35 (6):1788-1791. Epub 10/30/2020.
Rodgers TD, Williams AM, Baran A, Reagan PM, Casulo C, Zent CS, Evans A, Friedberg JW, Barr PM
Leukemia & lymphoma.. 2021 March 62 (3):598-605. Epub 10/25/2020.
Moore JE, Delibert K, Baran AM, Evans AG, Liesveld JL, Zent CS
Leukemia research.. 2021 March 102 :106522. Epub 02/04/2021.
Zent CS, Ross DM
Leukemia research.. 2021 January 100 :106510. Epub 01/13/2021.
Lipof JJ, Huselton EJ, Zent CS, Evans A, Zhang B, Rothberg PG, Bennett JM
Case reports in hematology.. 2021 2021 :5574766. Epub 07/03/2021.
Zent CS, Pinney JJ, Chu CC, Elliott MR
Antibodies.. 2020 December 19 (4)Epub 12/01/2020.
Pinney JJ, Rivera-Escalera F, Chu CC, Whitehead HE, VanDerMeid K, Nelson AM, Barbeau MC, Zent CS, Elliott MR
Blood.. 2020 October 29136 (18):2065-2079. Epub 1900 01 01.
Williams AM, van Wijngaarden E, Seplaki CL, Heckler CE, Weber MT, Barr PM, Zent CS, Janelsins MC
Leukemia & lymphoma.. 2020 July 61 (7):1627-1635. Epub 03/09/2020.
Meacham PJ, Williams AM, Strawderman M, Baran AM, Archibald WJ, Wallace DS, Tschernia NP, Burack WR, Barr PM, Zent CS
Leukemia & lymphoma.. 2020 July 61 (7):1636-1644. Epub 03/16/2020.
Parikh SA, Meacham PJ, Zent CS, Evans AG
Leukemia & lymphoma.. 2020 May 61 (5):1037-1051. Epub 01/11/2020.
Moore J, Baran AM, Meacham PJ, Evans AG, Barr PM, Zent CS
American journal of hematology.. 2020 May 95 (5):E108-E110. Epub 01/31/2020.
Chu CC, Pinney JJ, Whitehead HE, Rivera-Escalera F, VanDerMeid KR, Zent CS, Elliott MR
Journal of cell science.. 2020 March 5133 (5)Epub 03/05/2020.
Rodgers TD, Baran A, Reagan PM, Casulo C, Zent C, Evans A, Burack R, Williams AM, Friedberg JW, Barr PM
British journal of haematology.. 2020 February 188 (4):e33-e36. Epub 12/17/2019.
Chu CC, Pinney JJ, Whitehead HE, Rivera-Escalera F, VanDerMeid KR, Zent CS, Elliott MR
Journal of cell science.. 2020 January 1 Epub 01/01/2020.
Williams AM, Baran AM, Schaffer M, Bushart J, Rich L, Moore J, Barr PM, Zent CS
American journal of hematology.. 2020 January 95 (1):E16-E18. Epub 11/03/2019.
Oostindie SC, van der Horst HJ, Lindorfer MA, Cook EM, Tupitza JC, Zent CS, Burack R, VanDerMeid KR, Strumane K, Chamuleau MED, Mutis T, de Jong RN, Schuurman J, Breij ECW, Beurskens FJ, Parren PWHI, Taylor RP
Haematologica.. 2019 September 104 (9):1841-1852. Epub 02/21/2019.
Williams AM, Baran AM, Casulo C, Reagan P, Friedberg JW, Helber M, Moore J, Baloga E, Zent CS, Barr PM
Clinical lymphoma, myeloma & leukemia.. 2019 January 19 (1):41-47. Epub 10/13/2018.
Musilova K, Devan J, Cerna K, Seda V, Pavlasova G, Sharma S, Oppelt J, Pytlik R, Prochazka V, Prouzova Z, Trbusek M, Zlamalikova L, Liskova K, Kruzova L, Jarosova M, Mareckova A, Kornauth C, Simonitsch-Klupp I, Schiefer AI, Merkel O, Mocikova H, Burda P, Machova Polakova K, Kren L, Mayer J, Zent CS, Trneny M, Evans AG, Janikova A, Mraz M
Blood.. 2018 November 29132 (22):2389-2400. Epub 09/13/2018.
Mato AR, Roeker LE, Allan JN, Pagel JM, Brander DM, Hill BT, Cheson BD, Furman RR, Lamanna N, Tam CS, Handunnetti S, Jacobs R, Lansigan F, Bhavsar E, Barr PM, Shadman M, Skarbnik AP, Goy A, Beach DF, Svoboda J, Pu JJ, Sehgal AR, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Rhodes J, Ujjani CS, Nabhan C
American journal of hematology.. 2018 November 93 (11):1394-1401. Epub 09/26/2018.
VanDerMeid KR, Elliott MR, Baran AM, Barr PM, Chu CC, Zent CS
Cancer immunology research.. 2018 October 6 (10):1150-1160. Epub 08/08/2018.
Mato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C
Haematologica.. 2018 September 103 (9):1511-1517. Epub 06/07/2018.
Archibald WJ, Meacham PJ, Williams AM, Baran AM, Victor AI, Barr PM, Sahasrahbudhe DM, Zent CS
Leukemia research.. 2018 August 71 :43-46. Epub 07/06/2018.
Mato AR, Nabhan C, Thompson MC, Lamanna N, Brander DM, Hill B, Howlett C, Skarbnik A, Cheson BD, Zent C, Pu J, Kiselev P, Goy A, Claxton D, Isaack K, Kennard KH, Timlin C, Landsburg D, Winter A, Nasta SD, Bachow SH, Schuster SJ, Dorsey C, Svoboda J, Barr P, Ujjani CS
Haematologica.. 2018 May 103 (5):874-879. Epub 02/01/2018.
Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, Gupta N, Janelsins MC, Barr PM, Zent CS
Leukemia & lymphoma.. 2018 March 59 (3):625-632. Epub 07/11/2017.
Helber MJ, Moore JE, Williams AM, Meacham PJ, Rothberg PG, Zent CS
American journal of hematology.. 2017 September 92 (9):E542-E544. Epub 06/09/2017.
Taylor RP, Lindorfer MA, Cook EM, Beurskens FJ, Schuurman J, Parren PWHI, Zent CS, VanDerMeid KR, Burack R, Mizuno M, Paul Morgan B
Clinical immunology : the official journal of the Clinical Immunology Society.. 2017 August 181 :24-28. Epub 05/31/2017.
Murphy EJ, Neuberg DS, Rassenti LZ, Hayes G, Redd R, Emson C, Li K, Brown JR, Wierda WG, Turner S, Greaves AW, Zent CS, Byrd JC, McConnel C, Barrientos J, Kay N, Hellerstein MK, Chiorazzi N, Kipps TJ, Rai KR
Leukemia.. 2017 June 31 (6):1348-1354. Epub 01/24/2017.
Mato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, Howlett C, Skarbnik AP, Cheson BD, Zent CS, Pu JJ, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter AM, Cruz AL, Claxton DF, Goy A, Daniel C, Isaac K, Kennard KH, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster SJ, Nabhan C
Annals of oncology : official journal of the European Society for Medical Oncology. 2017 May 128 (5):1050-1056. Epub 1900 01 01.
Zent CS, Elliott MR
The FEBS journal.. 2017 April 284 (7):1021-1039. Epub 11/29/2016.
Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B
Blood.. 2017 February 2129 (5):553-560. Epub 11/30/2016.
Mato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, Howlett C, Skarbnik AP, Cheson BD, Zent CS, Pu JJ, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter AM, Cruz AL, Claxton DF, Goy A, Daniel C, Isaac K, Kennard KH, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster SJ, Nabhan C
Annals of oncology : official journal of the European Society for Medical Oncology. 2017 January 27 Epub 01/27/2017.
Mato AR, Nabhan C, Barr PM, Ujjani CS, Hill BT, Lamanna N, Skarbnik AP, Howlett C, Pu JJ, Sehgal AR, Strelec LE, Vandegrift A, Fitzpatrick DM, Zent CS, Feldman T, Goy A, Claxton DF, Bachow SH, Kaur G, Svoboda J, Nasta SD, Porter D, Landsburg DJ, Schuster SJ, Cheson BD, Kiselev P, Evens AM
Blood.. 2016 November 3128 (18):2199-2205. Epub 09/06/2016.
Zent CS
Blood.. 2016 October 13128 (15):1908-1909. Epub 1900 01 01.
Cook EM, Lindorfer MA, van der Horst H, Oostindie S, Beurskens FJ, Schuurman J, Zent CS, Burack R, Parren PW, Taylor RP
The Journal of immunology : official journal of the American Association of Immunologists.. 2016 September 1197 (5):1762-75. Epub 07/29/2016.
Williams AM, Zent CS, Janelsins MC
British journal of haematology.. 2016 September 174 (6):835-46. Epub 07/08/2016.
Zent CS, Bowen DA, Conte MJ, LaPlant BR, Call TG
Leukemia & lymphoma.. 2016 July 57 (7):1585-91. Epub 12/24/2015.
Zent CS
Leukemia & lymphoma.. 2016 May 57 (5):985-6. Epub 01/04/2016.
Zent CS, Wang XV, Ketterling RP, Hanson CA, Libby EN, Barrientos JC, Call TG, Chang JE, Liu JJ, Calvo AR, Lazarus HM, Rowe JM, Luger SM, Litzow MR, Tallman MS
American journal of hematology.. 2016 March 91 (3):308-12. Epub 02/09/2016.
Lindorfer MA, Cook EM, Tupitza JC, Zent CS, Burack R, de Jong RN, Beurskens FJ, Schuurman J, Parren PW, Taylor RP
Molecular immunology.. 2016 February 70 :13-23. Epub 12/12/2015.
Church AK, VanDerMeid KR, Baig NA, Baran AM, Witzig TE, Nowakowski GS, Zent CS
Clinical and experimental immunology.. 2016 January 183 (1):90-101. Epub 10/28/2015.
Bowen DA, Rabe KG, Schwager SM, Slager SL, Call TG, Viswanatha DS, Zent CS
Leukemia & lymphoma.. 2015 February 56 (2):311-4. Epub 06/25/2014.
Zent CS, Call TG, Bowen DA, Conte MJ, LaPlant BR, Witzig TE, Ansell SM, Weiner GJ
Leukemia & lymphoma.. 2015 56 (8):2373-8. Epub 03/17/2015.
Stilgenbauer S, Furman RR, Zent CS
American Society of Clinical Oncology educational book. 2015 :164-75. Epub 1900 01 01.
Zent CS, Burack WR
Hematology. 2014 December 52014 (1):119-24. Epub 11/18/2014.
Barr PM, Zent CS
Leukemia & lymphoma.. 2014 December 55 (12):2683-4. Epub 05/16/2014.
Conte MJ, Bowen DA, Wiseman GA, Rabe KG, Slager SL, Schwager SM, Call TG, Viswanatha DS, Zent CS
Leukemia & lymphoma.. 2014 September 55 (9):2079-84. Epub 02/17/2014.
Call TG, Norman AD, Hanson CA, Achenbach SJ, Kay NE, Zent CS, Ding W, Cerhan JR, Rabe KG, Vachon CM, Hallberg EJ, Shanafelt TD, Slager SL
Cancer.. 2014 July 1120 (13):2000-5. Epub 04/07/2014.
Zent CS, Taylor RP, Lindorfer MA, Beum PV, LaPlant B, Wu W, Call TG, Bowen DA, Conte MJ, Frederick LA, Link BK, Blackwell SE, Veeramani S, Baig NA, Viswanatha DS, Weiner GJ, Witzig TE
American journal of hematology.. 2014 July 89 (7):757-65. Epub 04/26/2014.
Slager SL, Zent CS
Leukemia & lymphoma.. 2014 April 55 (4):735-6. Epub 11/01/2013.
Baig NA, Taylor RP, Lindorfer MA, Church AK, LaPlant BR, Pettinger AM, Shanafelt TD, Nowakowski GS, Zent CS
The Journal of immunology : official journal of the American Association of Immunologists.. 2014 February 15192 (4):1620-9. Epub 01/15/2014.
The ABC of CLL: Etiology of cytopenias is important in staging and management
Barr, PM; Zent, CS.
Leuk Lymphoma. 2014; 55: 12-19.
Shanafelt T, Lanasa MC, Call TG, Beaven AW, Leis JF, LaPlant B, Bowen D, Conte M, Jelinek DF, Hanson CA, Kay NE, Zent CS
Cancer.. 2013 November 1119 (21):3788-96. Epub 08/06/2013.
Charbonneau B, Wang AH, Maurer MJ, Asmann YW, Zent CS, Link BK, Ansell SM, Weiner GJ, Ozsan N, Feldman AL, Witzig TE, Cunningham JM, Dogan A, Habermann TM, Slager SL, Novak AJ, Cerhan JR
Cancer immunology, immunotherapy : CII.. 2013 September 62 (9):1475-84. Epub 06/28/2013.
Parikh SA, Rabe KG, Call TG, Zent CS, Habermann TM, Ding W, Leis JF, Schwager SM, Hanson CA, Macon WR, Kay NE, Slager SL, Shanafelt TD
British journal of haematology.. 2013 September 162 (6):774-82. Epub 07/11/2013.
Witzig TE, Wiseman GA, Maurer MJ, Habermann TM, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Link BK, Zent CS, Johnston PB, Shanafelt TD, Allmer C, Asmann YW, Gupta M, Ballas ZK, Smith BJ, Weiner GJ
American journal of hematology.. 2013 July 88 (7):589-93. Epub 06/12/2013.
Gonsalves WI, Zent CS, Pulido JS, Patnaik MM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 June 1031 (17):e280-2. Epub 05/06/2013.
Shanafelt TD, Ramsay AG, Zent CS, Leis JF, Tun HW, Call TG, LaPlant B, Bowen D, Pettinger A, Jelinek DF, Hanson CA, Kay NE
Blood.. 2013 May 16121 (20):4137-41. Epub 03/14/2013.
Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, Leung N, Dingli D, Dispenzieri A
American journal of hematology.. 2013 May 88 (5):375-8. Epub 03/19/2013.
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphpocytic leukemia
Shanafelt, TD; Call, TG; Zent, CS; Leis, JF; LaPlant, B; Bowen, DA; Roos, M; Laumann, K; Ghosh, AK; Lesnick, C; Lee, MJ; Yang, CS; Jelinek, DF; Erlichman, C; Kay, NE.
Cancer. 2013; 119(2): 363-70.
Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphpocytic leukemia with alemtuzumab and rituximab
Zent, CS; Wu, W; Bowen, DA; Hanson, CA; Pettinger, AM; Shanafelt, TD; Kay, NE; Leis, JF; Call, TG.
Leuk Lymphoma. 2013; 54(3): 476-82.
Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis
Greipp, PT; Smoley, SA; Viswanatha, DS; Frederick, LS; Rabe, KG; Sharma, RG; Slager, SL; Van Dyke, DL; Shanafelt, TD; Tschumper, RC; Zent, CS.
Br J Haematol. 2013; 163(3): 326-33.
Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Schwager SM, Leis JF, Jelinek DF, Slager SL, Hanson CA
Leukemia.. 2012 February 26 (2):373-6. Epub 08/12/2011.
Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?
Lindorfer MA; Wiestner A; Zent CS; Taylor RP.
Oncoimmunology. 2012; 1(6): 959-61.
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
Zent CS; Smith BJ; Ballas ZK; Wooldridge JE; Link BK; Call TG; Shanafelt; TD; Bowen DA; Kay NE; Witzig TE; Weinier GJ.
Leuk Lymphoma. 2012; 53(2): 211-7.
Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)
Gustafson MP; Abraham RS; Lin Y; Wu W; Gastineau DA; Zent CS; Dietz AB.
Br J Haematol. 2012; 156(5): 674-6.
Hematologist/oncologist disease-specific expertise and survival: lessions from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG.
Cancer. 2012; 118(7): 1827-37.
Improving quality of life in chronic lymphocytic leukemia
Zent CS.
Leuk Lymphoma. 2012; 53(7): 1247-8.
Anti-CD20 antibody therapy for B-cell lymphomas
Taylor RP; Lindorfer MA; Zent CS.
N Engl J Med. 2012; 367(9): 876-7.
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma
Charbonneau B; Maurer MJ; Fredericksen ZS; Zent CS; Link BK; Novak AJ; Ansell SM; WeinerGJ; Wang AH; Witzig TE; Dogan A; Slager SL; Habermann TM; Cerhan JR.
Am J Hematol. 2012; 87(9): 880-5.
Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Schwager SM; Leis JF; Jelinek DF; Slager SL; Hanson CA.
Leukemia. 2012; 26(2): 373-6.
Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement
Baig NA; Taylor RP; Lindorfer MA; Church AK; LaPlant Br; Pavey ES; Nowakowski GS; Zent CS.
Leuk Lymphoma. 2012; 53(11): 2218-27.
Differentiation of chronic lymphocytic leukemia B-cells into immunoglobulin secreting cells decreases LEF-1 expression
Gutierrez A; Arendt BK; Tschumper RC; Kay NE; Zent CS; Jelinek DF.
PLoS One. 2011; 6(10): e26056.
Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia
Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GH; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR.
Blood. 2011; 117(5): 1492-8.
FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes
Zent CS; Polliack A; Tadmor T.
Leuk Lymphoma. 2011; 52(6): 946-7.
A case of hairy cell leukemia with CCND1-IGH translocation: indolent non-nodal mantle cell lymphoma revisited
Chen D; Kettering RP; Hanson CA; Colgan JP; Zent CS; Viswanatha DS.
Am J Surg Pathol. 2011; 35(7): 1080-4.
Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach
Zent CS; Kay NE.
Leuk Lymphoma. 2011; 52(8): 1425-34.
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia
Maurer MJ; Cerhan JR; Katzmann JA; Link BK; Allmer C; Zent CS; Call TG; Rabe KG; Hanson CA; Kay NE; Slager SL; Witzig TE; Shanafelt TD.
Blood. 2011; 118(10): 2821-6.
Multi-parameter prognostication in chronic lymphocytic leukemia
Zent CS.
Leuk Lymphoma. 2011; 52(10): 1823-4.
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance
Mraz M; Zent CS; Church AK; Jelinek DF; Wu X.
Br J Haematol. 2011; 155(1): 53-64.
Shanafelt TD, Rabe KG, Kay NE, Zent CS, Jelinek DF, Reinalda MS, Schwager SM, Bowen DA, Slager SL, Hanson CA, Call TG
Cancer.. 2010 October 15116 (20):4777-87. Epub 1900 01 01.
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity
Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS.
Cytometry B Clin Cytom. 2010; 58(Suppl 1): S35-41.
A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
Van Dyke DL; Shanafelt TD; Call TG; Zent CS; Smoley SA; Rabe KG; Schwager SM; Sonbert JC; Slager SL; Kay NE.
Br J Haematol. 2010; 148(4): 544-50.
Detection of recurrent chromosomal defects in chronic lymphocytic leukemia/small lymphocytic lymphoma: innovations and applications
Zent CS; Van Dyke DL.
Leuk Lymphoma. 2010; 51(2): 186-7.
Autoimmune complications in chronic lymphocytic leukaemia (CLL)
Zent CS; Kay NE.
Best Pract Res Clin Haematol. 2010; 23(1): 47-59.
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone
Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager RM; Reinalda MS; Rabe KG; Slager SL; Zent CS.
Leuk Lymphoma. 2010; 51(4): 620-7.
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation
Zent CS; LaPlant BR; Johnston PB; Call TG; Habermann TM; Micallef IN; Witzig TE.
Cancer. 2010; 116(9): 2201-7.
Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia
Kay NE; Wu W; Kabat B; LaPlant B; Lin TS; Byrd JC; Jelinek DF; Grever MR; Zent CS; Call TG; Shanafelt TD.
Cancer. 2010; 116(9): 2180-7.
Time to test CLL p53 function
Zent CS.
Blood. 2010; 115(21): 4154-5.
Recurrent fevers, cough, and pulmonary opacities in a middle-aged man
Bauer PR; Zent CS; Aubry MC; Ryu JH.
Chest. 2010; 137(6): 1465-9.
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chornic lymphocytic leukemia
Shanafelt, TD; Rabe, KG; Kay, NE; Zent, CS; Call, TG; Slager, SL; Bowen, DA; Schwager, SM; Nowakowski, GS.
Leuk Lymphoma. 2010; 51(7): 1233-40.
Chronic Lymphocytic Leukemia in the Elderly: Who Should be Treated?
Zent CS.
Am Soc Clin Oncol Ed. 2010; : 268-71.
CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma
Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PG; Zent CS.
Leuk Res. 2010; 34(9): 1235-8.
Cell-mediated immunity in chronic lymphocytic leukemia
Zent CS.
Leuk Lymphoma. 2010; 51(10): 1775-6.
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
Shanafelt TD; Rabe KG; Kay NE; Zent CS; Jelinek DF; Reinalda MS; Schwager SM; Bowen DA; Slager SL; Hanson CA; Call TG.
Cancer. 2010; 116(20): 4777-87.
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia
Shanafelt T; Zent C; Byrd J; Erlichman C; LaPlant B; Ghosh A; Call T; Villalona-Calero M; Jelinek D; Bowen D; Laumann K; Wu W; Hanson C; Kay N.
Leuk Lymphoma. 2010; 51(12): 2222-9.
Pardanani A, Tefferi A, Litzow MR, Zent C, Hogan WJ, McClure RF, Viswanatha D
Blood.. 2009 October 15114 (16):3502-3. Epub 1900 01 01.
Awan FT, Kay NE, Davis ME, Wu W, Geyer SM, Leung N, Jelinek DF, Tschumper RC, Secreto CR, Lin TS, Grever MR, Shanafelt TD, Zent CS, Call TG, Heerema NA, Lozanski G, Byrd JC, Lucas DM
Blood.. 2009 January 15113 (3):535-7. Epub 11/13/2008.
Validation of a new prognostic index for patients with chronic lymphocytic leukemia
Shanafelt TD; Jenkins G; Call TG; Zent CS; Slager S; Bowen DA; Schwager S; Hanson CA; Jelinek DF; Kay NE.
Cancer. 2009; 115(2): 363-72.
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia
Shanafelt TD; Bowen DA; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Tun H; Sloan JA; Call TG.
Leuk Res. 2009; 33(2): 263-70.
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia
Nowakowski GS; Hoyer JD; Shanafelt TD; Zent CS; Call TG; Bone ND; Laplant B; Dewald GW; Tschumper RC; Jelinek DF; Witzig TE; Kay NE.
J Clin Oncol. 2009; 27(11): 1844-9.
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA.
Blood. 2009; 113(18): 4188-96.
Management of autoimmune cytopenia complicating chronic lymphocytic leukemia
Zent CS; Shanafelt T.
Leuk Lymphoma. 2009; 50(6): 863-4.
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis
Zent CS; Ding W; Reinalda MS; Schwager SM; Hoyer JD; Bowen DA; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Kay NE; Slager SL.
Leuk Lymphoma. 2009; 50(8): 1261-8.
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia
Shanafelt TD; Call TG; Zent CS; LaPlant B; Bowen DA; Roos M; Secreto CR; Ghosh AK; Kabat BF; Lee MJ; Yang CS; Jelinek DF; Erlichman C; Kay NE.
J Clin Oncol. 2009; 27(23): 3808-14.
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA.
J Clin Oncol. 2009; 27(24): 3959-63.
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia
Shanafelt TD; Byrd JC; LaPlant B; Zent CS; Call T; Secreto C; Grever MR; Lin TS; Kay NE.
Br J Haematol. 2009; 146(6): 660-4.
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression
Ding W; Nowakowski GS; Knox TR; Boysen JC; Maas ML; Schwager SM; Wu W; Wellik LE; Dietz AB; Ghosh AK; Secreto CR; Medina KL; Shanafelt TD; Zent CS; Call TG; Kay NE.
Br J Haematol. 2009; 147(4): 471-83.
Holtan SG, Porrata LF, Colgan JP, Zent CS, Habermann TM, Markovic SN
American journal of hematology.. 2008 August 83 (8):688-9. Epub 1900 01 01.
Hogan WJ, Zent CS
Leukemia & lymphoma.. 2008 May 49 (5):835-6. Epub 1900 01 01.
Zent CS
Leukemia & lymphoma.. 2008 February 49 (2):175-6. Epub 1900 01 01.
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia
Thurmes P; Call T; Slager S; Zent C; Jenkins, G; Schwager S; Bowen, D; Kay NE; Shanafelt T.
Leuk Lymphoma. 2008; 49(1): 49-56.
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia
Palmer S; Hanson CA; Zent CS; Porrata LF; Laplant B; Geyer SM; Markovic SN; Call TG; Bowen DA; Jelinek DF; Kay NE; Shanafelt TD.
Br J Haematol. 2008; 141(5): 607-14.
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients
Tschumper RC; Geyer SM; Campbell ME; Kay NE; Shanafelt TD; Zent CS; Nowakowski GS; Call TG; Dewald GW; Jelinek DF.
J Clin Invest. 2008; 118(1): 306-15.
CD49d expression is an independent predictor of overall survival i npatients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
Shanafelt TD; Geyer SM; Bone ND; Tschumper RC; Witzig TE; Nowakowski GS; Zent CS; Call TG; Laplant B; Dewald GW; Jelinek DF; Kay NE.
Br J Haematol. 2008; 140(5): 537-46.
Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma
Hogan WJ; Zent CS.
Leuk Lymphoma. 2008; 49(5): 835-6.
The prognostic significant of cytopenia in chronoc lymphocytic leukaemia/small lymphocytic lymphoma
Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL.
Br J Haematol. 2008; 141(5): 615-21.
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count , greater than or equal to 5 x 10e9/L but a B-cell lymphocyte count less than or equal to 5 x 10e9/L?
Shanafelt TD; Kay NE; Cell TG; Zent CS; Jelinek DF; LaPlant B; Morice WG; Hanson CA.
Leuk Res. 2008; 32(9): 1458-61.
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
Zent CS; Call TG' Shanafelt TD; Tschumper RC; Jelinek DF; Bowen DA; Secreto CR; Laplant BR; Kabat BF; Kay NE.
Cancer. 2008; 113(8): 2110-8.
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab
Zent CS; Secreto CR; LaPlant BR; Bone ND; Call TG; Shanafelt TD; Jelinek DF; Tschumper RC; Kay NE.
Leuk Res. 2008; 32(12): 1849-56.
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia
Kay NE; Geyer SM; Call TG; Shanafelt TD; Zent CS; Jelinek DF; Tschumper R; Bone ND; Dewald GW; Lin TS; Heerema NA; Smith L; Grever MR; Byrd JC.
Blood. 2007; 109(2): 405-11.
Mantle cell lymphoma presenting as a slowly enlarging lesion of the floor of mouth in a healthy 72 year old: report of a case
Rockacy J; Viozzi CF; Zent CS.
J Oral Maxillofac Surg. 2007; 65(2): 333-7.
Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/small lymphocytic lymphoma
Ding W; Zent CS.
Clin Adv Hematol Oncol. 2007; 5(4): 257-61.
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test
Nowakowski GS; Hoyer JD; Shanafelt, TD; Geyer, SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE.
Mayo Clin Proc. 2007; 82(4): 449-53.
Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia
Shanafelt TD; Lin T; Geyer SM; Zent CS; Leung N; Kabat B; Bowen D; Grever MR; Byrd JC; Kay NE.
Cancer. 2007; 109(11): 2291-8.
Chronic lymphocytic leukemia: biology and current treatment
Zent CS; Kay NE.
Curr Oncol Rep. 2007; 9(5): 345-52.
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients
Shanafelt TD; Bowen D; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Sloan JA; Call TG.
Br J Haematol. 2007; 139(2): 255-64.
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia
Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD.
Br J Haematol. 2007; 139(3): 398-404.
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features
Bowen DA; Call TG; Jenkins GD; Zent CS; Schwager SM; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD.
Leuk Lymphoma. 2007; 48(12): 2412-7.
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia
Browning RL; Geyer SM; Johnson AJ; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Zent CS; Bone ND; Dewald GW; Lin TS; Heerema NA; Gever MR; Kay NE; Byrd JC; Lucas DM.
Leuk Res. 2007; 49(1): 49-56.
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia
Stockero KJ; Fink SR; Smoley SA; Paternoster SF; Shanafelt TD; Call TG; Zent CS; Van Dyke DL; Kay NE; Dewald GW.
Cancer Genet Cytogenet. 2006; 166(2): 152-6.
Loss of TP53 due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia
Fink SR; Smoley SA; Stockero KJ; Paternoster SF; Thorland EC; Van Dyke DL; Shanafelt TD; Zent CS; Call TG; Kay NE; Dewald GW.
Cancer Genet Cytogenet. 2006; 167(2): 177-81.
Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature
Osborn NK; Ustundag Y; Zent CS; Wiesner RH; Rosen CB; Narayanan Menon KV.
Am J Transplant. 2006; 6(7): 1743-5.
Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes
Nora EH; Hamacher KL; Zent CS; Ghosh AK.
South Med J. 2006; 99(8): 876-9.
Autoimmunity and chronic lymphocytic leukemia
Zent CS.
Leuk Lymphoma. 2006; 47(8): 1443-4.
Intravascular B-cell lymphoma (angiotropic lymphoma) with choroidal involvement
Lee HB; Pulido JS; Buettner H; Salomao D; Zent CS; Link TP.
Arch Ophthalmol. 2006; 124(9): 1357-9.
Update on risk-stratified management for chronic lymphocytic leukemia
Zent CS; Call TG; Hogan WJ; Shanafelt TD; Kay NE.
Leuk Lymphoma. 2006; 47(9): 1738-46.
Narrative review: initial management for chronic lymphocytic leukemia
Shanafelt TD; Byrd JC; Call TG; Zent CS; Kay NE.
Ann Intern Med. 2006; 145(6): 435-47.
Chronic B-cell lymphoproliferative disorders: how many diseases?
Zent CS.
Leuk Lymphoma. 2006; 47(10): 2006-7.
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia
Shanafelt TD; Witzig TE; Fink SR; Jenkins RB; Paternoster SF; Smoley SA; Stockero KJ; Nast DM; Flynn HC; Tschumper RC; Geyer S; Zent CS; Call TG; Jelinek DF; Kay NE.
J Clin Oncol. 2006; 24(28): 4634-41.
Staging chronic lymphocytic leukemia (CLL) for prognosis at diagnosis
Zent CS; Polliack A.
Leuk Lymphoma. 2006; 47(12): 2433-4.
Clinical significance of monoclonal B cells in cerebrospinal fluid
Nowakowski GS, Call TG; Morice WG; Kurtin PJ; Cook RJ; Zent CS.
Cytometry B Clin Cytom. 2005; 63(1): 23-7.
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia
Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS.
Br J Haematol. 2005; 130(1): 36-42.
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies
Shanafelt TD; Lee YK; Call TG; Nowakowski GS; Dingli D; Zent CS; Kay NE.
Leuk Res. 2005; 30(6): 707-12.
Update on monoclonal antibody therapy in chronic lymphocytic leukemia
Zent CS; Kay NE.
Clin Adv Hematol Oncol. 2004; 2(2): 107-13.
The academic hematology-oncology firm: a model for postgraduate cancer education
Kohli M; Zent C; Hutchins LF; Safar M; Dotson P; Mehta P.
J Cancer Educ. 2004; 19(1): 45-9.
Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS.
Leuk Lymphoma. 2004; 45(3): 507-13.
Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium
Zent CS; Chen JB; Kurten RC; Kaushal GP; Lacy HM; Schichman SA.
Leuk Res. 2004; 28(5): 495-507.
Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia
Zent CS; Kay NE.
Curr Oncol Rep. 2004; 6(5): 348-54.
Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma
Kyasa MJ; Parrish RS; Schichman SA; Zent CS.
Am J Hematol. 2003; 74(1): 1-8.
The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype
Zent CS; Zhan FG; Schichman SA; Bumm KHW; Lin P; Chen JB; Shaughnessy JD.
Leuk Res. 2003; 27(9): 765-74.
Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer
Kohli M; Fink LM; Spencer JH; Zent CS.
Blood Coagul Fibrinolysis. 2002; 13(1): 1-5.
Linezolid-induced pure red blood cell aplasia
Monson T; Schichman SA; Zent CS.
Clin Infect Dis. 2002; 35(3): E29-31.
Anemia and chronic disease
Zent C.
US Medicine. 2001; 37(5 Suppl): 5-8.
Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data
Zent CS; Kyasa MJ; Evans R; Schichman SA.
Cancer. 2001; 92(5): 1325-30.
Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma
Joseph L; Scott MA; Schichman SA; Zent CS.
Am J Hematol. 2001; 68(4): 287-91.
Use of HFE mutation analysis for hereditary hemochromatosis: the need for physician education in the translation of basic science to clinical practice
Kohli M; Schichman SA; Fink L; Zent CS.
South Med J. 2000; 93(5): 469-71.
Govindarajan R, Baxter D, Wilson C, Zent C
American journal of hematology.. 1999 October 62 (2):122-3. Epub 1900 01 01.
Relationship between megakaryoctye mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura
Zent CS; Ratajczak J; Ratajczak MZ; Anastasi J; Hoffman PC; Gewirtz AM.
Br J Haematol. 1999; 105(2): 452-8.
Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation
Zent CS; Wilson CS; Tricot G; Jagannath S; Siegel D; Desikan KR; Munshi N; Bracy D; Barlogie B; Butch AW.
Blood. 1998; 91(9): 3518-23.
Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies
Zent C; Rowley JD; Nucifora G.
Leukemia. 1997; 3(11 Suppl): 273-8.
Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression nof co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigneic properties
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G.
Current Topics in Microbiology & Immunology. 1996; 211: 243-52.
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties
Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G.
Proc Natl Acad Sci. 1996; 93(3): 1044-8.
Toxicity of anti-tuberculous medication
Zent CS.
S. Afr J of Epidemiology and Infection. 1994; 9(1): 5-9.
Drug allergy
Zent C, Smith P.
S AFr Med J. 1994; 84(5): 281-286.
Prediction of amikacin dose requirements in neutropenic patients with haematological disease
Zent CS, Allin R, Folb PI.
S. Afr Med J. 1993; 82(11): 853-854.
Books
ASH-SAP American Society of Hematology Self-Assessment Program (2016)
Chapter: Chronic lymphocytic leukemia/small lymphocytic lymphoma.
Authors: Zent CS, Call TG
Publisher: American Society of Hematology 2016
Companion to Peripheral Neuropathy: Illustrated Cases and New Developments (2010)
Chapter: Chronic lymphocytic leukemia causing multiple mononeuropathies
Authors: Mauermann ML, Zent CS, Low PA
Publisher: Saunders/Elsevier, Philadelphia 2010
Textbook of Medicine (2010)
Chapter: Disorders of the Blood
Authors: Zent C and Polliack A
Publisher: Oxford 2010
Interferons: biological activities and clinical efficacy (1997)
Chapter: Treatment options for hairy cell leukemia
Authors: Zent CS and Golomb HM
Publisher: Springer, Berlin 1997
The Chemotherapy Source Book (1996)
Chapter: Acute leukmia in adults
Authors: Zent CS, Larson RA
Publisher: Williams and Wilkins, Baltimore, MD 1996
Current Therapy in Hematology-Oncology (1995)
Chapter: Hairy Cell Leukemia
Authors: Zent CS, Golomb HM
Publisher: Mosby, St. Louis, MO 1995
South African National Formulary (1995)
Chapter: Anti-infectives for systemic use
Authors: Zent CS
Publisher: MASA, Cape Town 1995
Ratings & Comments
At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.
Ratings
During this visit, did this provider spend enough time with you?
During this visit, did this provider show respect for what you had to say?
During this visit did this provider give you easy to understand information about these health questions or concerns?
During this visit, did this provider listen carefully to you?
During this visit, did this provider explain things in a way that was easy to understand?
Patient Comments
I am blessed to have such a knowledgeable, caring and professional doctor!!
Jun 30, 2024
In addition to my regular CLL checkup, I asked questions about prescriptions given by Urgent Care and about protection from insect stings. Dr. Zent always provides common sense answers and advice. He and his staff care are professional, and up to date on care for my needs.
Jun 11, 2024
Dr. Zent is outstanding. I feel very fortunate that he is my specialist.
May 09, 2024
Doctor Zent is a good physician I am glad he was recommended for my Oncologist.
May 04, 2024
I drive 5 hours [...] because Dr. Zent is the best
Apr 20, 2024
Dr. Zent is always thorough in explaining my health conditions and answer our questions.
Apr 08, 2024
Even though it was a most unusual day, my provider did not rush through the appointment.
Feb 21, 2024
Definitely would recommend Dr. Zent
Jan 24, 2024
Have recommended this provider and his team. You can't get any better care
Nov 23, 2023
I consider myself fortunate to have Dr Zent providing my care.
Nov 20, 2023
Dr. Zent saved my life
Nov 09, 2023
Dr. Zent is always willing to discuss my illness and treatment options in as much detail and depth as I request, including waiting for me to catch up when I'm taking notes.
Nov 04, 2023
Dr. Zent is an excellent doctor who provides very good care to his patients.
Aug 14, 2023
Excellent care
Jul 20, 2023
He is very good at what he does.
Jul 18, 2023
Dr. Zent considers the entire constellation of a person's health issues while monitoring CLL In my case it consists of comorbidities with MS and metastatic prostate cancer. I find it especially reassuring that he looks at the whole picture. He listens carefully and I never feel rushed. He patiently provides advice and explanations.
Jun 28, 2023
Dr. Zent is the most knowledgeable kindest doctor in the whole world
Jun 25, 2023
Dr. Zent is an exceptional doctor. I am very satisfied with the care he provides.
Jun 25, 2023
Dr. Zent always asks if you have any questions regarding what he is telling you.
Apr 07, 2023
Great drs. great staff.
Feb 14, 2023
I do not recommend.
Feb 13, 2023
Explanation sometimes became very technical.
Dec 17, 2022
Provider is of high quality
Nov 12, 2022
Always an excellent experience in the office, and always (during the work week) prompt replies to my questions through the portal. But I have to say I spent a very anxious weekend after this last visit because a question I sent on the portal wasn't replied to until Monday morning, I understand... but It was rough.
Oct 28, 2022
Excellent Care
Oct 14, 2022
Everything went very smoothly as expected.
Oct 05, 2022
Great experience
Sep 27, 2022
Really liked Dr Zent. Explained everything, very easy to understand. Showed real concern for issues
Sep 25, 2022
Saved my life.
Aug 17, 2022
Dr. Zent really cares about his patients.
Jul 21, 2022
The best doctor in the whole world
Jul 21, 2022
We are VERY FORTUNATE to have Dr. Zent on staff at WILMOT!!!
Jun 17, 2022
Dr Zent is excellent as my health care provider
Jun 15, 2022
Dr. Zent is an excellent doctor.
May 06, 2022
Dr. Zent and I had both researched the same new treatment and concluded it was not right for me, also he diagnosed a skin issue that had been misdiagnosed by my Dermatologist so I will be switching to the dermatologist who works with Dr Zent's patients (Dr. Manavva). We decided based on the experience between the last two treatments that we need to move them closer together. All decisions were very collaborative, and I felt like he listened with respect to my opinions and feedback.
Mar 24, 2022
Dr. Zent is one of two doctors I've had in my life who I consider top of their field. He is concerned with my whole health [...].
Mar 01, 2022
Dr. Zent is an excellent doctor, very knowledgeable and caring.
Feb 01, 2022